Xinshubao tablet ameliorates myocardial injury against heart failure via the DCN/PPARα/PGC-1α/P300 pathway
Heart failure (HF) is a complex clinical syndrome with impaired ventricular ability due to structural or functional cardiac disorders. A traditional Chinese formula named Xinshubao tablet (XSB) is reported to protect cardiomyocytes and decrease the risk of HF clinically; however, the underlying mech...
Main Authors: | Qingqing Cai, Yu Li, Yi Zhang, He Xu, Lifang Wang, Jixiang Tian, Fangbo Zhang, Hongjun Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332223010764 |
Similar Items
-
PXR Suppresses PPARα-Dependent <i>HMGCS2</i> Gene Transcription by Inhibiting the Interaction between PPARα and PGC1α
by: Ryota Shizu, et al.
Published: (2021-12-01) -
Sustained PGC-1α2 or PGC-1α3 expression induces astrocyte dysfunction and degeneration
by: M.J. Nunes, et al.
Published: (2024-03-01) -
Therapeutic Potential of Ginsenoside Rb1-PLGA Nanoparticles for Heart Failure Treatment via the ROS/PPARα/PGC1α Pathway
by: Lixin Du, et al.
Published: (2023-12-01) -
Xinshubao tablet rescues cognitive dysfunction in a mouse model of vascular dementia: Involvement of neurogenesis and neuroinflammation
by: Hong-He Xiao, et al.
Published: (2024-03-01) -
Garcinol Promotes the Formation of Slow-Twitch Muscle Fibers by Inhibiting p300-Dependent Acetylation of PGC-1α
by: Weilei Yao, et al.
Published: (2023-01-01)